Acerus Pharmaceuticals Corporation

Canada · Reporting entity ID 100000736811

Total reported 2019–2025

$944K

#1,328 of 2,960 reporting companies — 0% of all reported industry payments

$423K in general payments across 8,396 records, plus $522K in research funding across 145 records.

How it breaks down

General payments $422,640

Research funding $521,722

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.